Cullinan Therapeutics
CGEM
#6903
Rank
$0.43 B
Marketcap
$7.41
Share price
-1.07%
Change (1 day)
-55.58%
Change (1 year)

Earnings for Cullinan Therapeutics (CGEM)

Earnings in 2024 (TTM): -$0.2 Billion USD

According to Cullinan Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -$0.2 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cullinan Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -$0.2 Billion3.29%
2023 -$0.2 Billion44.28%
2022 -$0.14 Billion94.45%
2021 -$67.96 Million12.63%
2020 -$60.34 Million